This inventor holds 2 USPTO granted patents. Top assignees: Kyowa Hakko Kirin Co., Limited, Kyowa Hakko Kogyo Co., Ltd.. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2011
Title: Maiko Hirota: Innovator in Antibody Development
Introduction
Maiko Hirota is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work has implications for cancer treatment and diagnostics, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Maiko Hirota holds 2 patents that focus on groundbreaking advancements in antibody technology. His latest patents include a humanized antibody against fibroblast growth factor-8 (FGF-8) and an antibody fragment thereof. This invention relates to an antibody that specifically targets FGF-8, along with a DNA sequence encoding the antibody, a vector containing the DNA sequence, and a host cell transformed by the vector. The patent also outlines a production process for the antibody or its fragment, as well as therapeutic and diagnostic agents for cancer utilizing these antibodies. Another significant patent is for an anti-fibroblast growth factor-8 monoclonal antibody, which describes a method for preventing or treating diseases by administering an effective amount of the monoclonal antibody that inhibits FGF-8 activity.
Career Highlights
Throughout his career, Maiko Hirota has worked with notable companies in the biotechnology sector. He has been associated with Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to innovative projects.
Collaborations
Maiko has collaborated with talented individuals such as Kenya Shitara and Naoki Shimada. These partnerships have played a crucial role in his research and development efforts, enhancing the impact of his inventions.
Conclusion
Maiko Hirota is a distinguished inventor whose work in antibody development is paving the way for advancements in cancer treatment. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile